- Home
- OCGN vs MOV Comparison
OCGN vs MOV Comparison
Compare OCGN & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- MOV
- Stock Information
- Founded
- OCGN 2013
- MOV 1961
- Country
- OCGN United States
- MOV United States
- Employees
- OCGN N/A
- MOV N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- MOV Consumer Specialties
- Sector
- OCGN Health Care
- MOV Consumer Discretionary
- Exchange
- OCGN Nasdaq
- MOV Nasdaq
- Market Cap
- OCGN 283.3M
- MOV 339.1M
- IPO Year
- OCGN N/A
- MOV 1993
- Fundamental
- Price
- OCGN $1.03
- MOV $19.47
- Analyst Decision
- OCGN Strong Buy
- MOV Strong Buy
- Analyst Count
- OCGN 3
- MOV 1
- Target Price
- OCGN $6.00
- MOV $31.50
- AVG Volume (30 Days)
- OCGN 1.8M
- MOV 168.5K
- Earning Date
- OCGN 08-01-2025
- MOV 08-28-2025
- Dividend Yield
- OCGN N/A
- MOV 7.19%
- EPS Growth
- OCGN N/A
- MOV N/A
- EPS
- OCGN N/A
- MOV 0.77
- Revenue
- OCGN $4,754,000.00
- MOV $655,597,000.00
- Revenue This Year
- OCGN N/A
- MOV $0.71
- Revenue Next Year
- OCGN N/A
- MOV N/A
- P/E Ratio
- OCGN N/A
- MOV $25.24
- Revenue Growth
- OCGN N/A
- MOV 0.79
- 52 Week Low
- OCGN $0.52
- MOV $12.85
- 52 Week High
- OCGN $1.29
- MOV $22.20
- Technical
- Relative Strength Index (RSI)
- OCGN 50.51
- MOV 77.54
- Support Level
- OCGN $1.00
- MOV $17.88
- Resistance Level
- OCGN $1.05
- MOV $17.55
- Average True Range (ATR)
- OCGN 0.04
- MOV 0.55
- MACD
- OCGN 0.00
- MOV 0.29
- Stochastic Oscillator
- OCGN 55.56
- MOV 91.08
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.